Carmine Therapeutics

About:

Carmine Therapeutics develops a novel type of gene therapy that utilizes extracellular vesicles produced in the laboratory.

Website: https://www.carminetherapeutics.com/

Top Investors: Simcere Pharma, Huagai Capital, Cystic Fibrosis Foundation, Esco Ventures, EVX Ventures

Description:

Carmine Therapeutics develops a novel type of gene therapy that utilizes extracellular vesicles produced in the laboratory.

Total Funding Amount:

$3.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2019-01-01

Contact Email:

yeo(AT)carminetherapeutics.com

Founders:

XiangQian (XQ) Lin

Number of Employees:

11-50

Last Funding Date:

2022-10-13

IPO Status:

Private

Industries: